Mirae Asset Global Etfs Holdings Ltd. Kymera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 30,793 shares of KYMR stock, worth $912,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,793
Previous 28,960
6.33%
Holding current value
$912,704
Previous $1.17 Million
27.73%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$199 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$191 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$178 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$178 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$155 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.62B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...